Deep Learning Enabled Endovascular Stroke Therapy Screening in Community Hospitals

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 443 participants.

Also called NCT05838456

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 443 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05838456
Other papers using this trial's data
  • Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times: A Cluster Randomized Clinical Trial JAMA neurology, 2023-11-01 DOI, PubMed 37721738, PMC10507590 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05838456. Randomized; no masking; primary purpose diagnostic. Start 2021-01-01 (actual); primary completion 2022-02-28 (actual). Results posted on 2023-06-28.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Deep Learning Enabled Endovascular Stroke Therapy Screening in Community Hospitals
Condition
Acute Ischemic Stroke (AIS)
Intervention (Device)
Viz.AI software
Lead sponsor
The University of Texas Health Science Center, Houston (class: other)
Collaborator
National Center for Advancing Translational Sciences (NCATS) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05838456
Content hash
b9ac966b1f3016ed9475a2cf0761e44253cc20f648b80b5c1cbd958402fa9fbb